UNITED NATIONS (Reuters) - U.N. Secretary-General Ban Ki-moon launched a $2.2 billion initiative on Tuesday to stamp out cholera over the next decade in impoverished Haiti, where an epidemic has killed thousands of people and been blamed on U.N. peacekeepers.
NEW YORK (Reuters Health) - The fictional James Bond always had a license to kill, but new research suggests the movies about the suave spy got more violent through the years.
NEW YORK (Reuters Health) - Men with azoospermia and HIV or hepatitis C should not be excluded from fertility programs, the lead author of a new report told Reuters Health.
NEW YORK (Reuters Health) - Added to standard CHOP chemotherapy, both rituximab and radioimmunotherapy (RIT) produce excellent results in patients presenting with advanced follicular lymphoma, a Southwest Oncology Group study shows.
NEW YORK (Reuters Health) - Intracranial pressure (ICP) monitoring after traumatic brain injury is no more effective at preventing death and cognitive complications than monitoring with CT scans and clinical observations, according to the first rigorous comparison of the two techniques.
ZURICH (Reuters) - Novartis AG's blood cancer drug Tasigna is better at treating a type of chronic myeloid leukemia than its older drug Gleevec, according to data from two late-stage trials, boosting prospects for its oncology franchise.
LISBON (Reuters) - An outbreak of dengue fever on Madeira island is waning after infecting 2,000 people in Europe's first sustained transmission since the 1920s, Portugal's health secretary Fernando Leal da Costa said on Monday.
LONDON (Reuters) - Britain's health ministry named a former practicing doctor, David Haslam, as the preferred candidate to chair the country's healthcare cost-effectiveness watchdog NICE on Monday.
NEW YORK (Reuters Health) - Ezetimibe (Zetia) and statins seem to protect equally well against major atherosclerotic disease and all-cause mortality, a study by US and Spanish researchers suggests.
NEW YORK (Reuters Health) - Prasugrel is as safe and effective as clopidogrel, when given after bivalirudin to patients with acute coronary syndrome (ACS) undergoing percutaneous coronary intervention (PCI), researchers say.